| answer text |
<p>‘Prescribed Medicines: An Evidence Review’ is a public health evidence review of
the published evidence and available data. This process is distinct from a public
inquiry so the inclusion of individual testimonies would not be appropriate.</p><p>
</p><p>Public Health England (PHE) is aware of the importance and relevance of the
experience of patients in understanding the issues. The review will give significant
prominence to the patients’ experiences and examine existing service models through
published research and other methods, for example analysis of annual reports of various
withdrawal charities.</p><p> </p><p>The call for evidence was open to all parties,
including pharmaceutical companies. The call for evidence has now closed. The National
Guideline Centre (NGC) will provide details on the evidence submitted in their rapid
evidence assessment report. The report is due in early 2019.</p><p> </p><p>A non-disclosure
agreement was not made between PHE and the NGC in relation to the review of literature
on prescribed medicines.</p>
|
|
